IOWA CITY, Iowa (IOWA'S NEWS NOW) — With the U.S. seemingly unable to stop the spread of COVID-19, the pressure is on to find a meaningful way to treat the virus. One new drug, from Regeneron, is so promising it recently received the green light for Phase 3 study. Researchers at the University of...
News
The Office of the Vice President for Research and the Human Subjects Office are providing updated guidance related to human subjects-related research visits. As research activities gradually resume on campus, the health and safety of research participants, study teams, faculty and staff must remain...
As some COVID-19 related restrictions are lifted across the state, the Office of the Vice President for Research and the Human Subjects Office are providing updated guidance related to human subjects-related research visits. While we prepare for research efforts to gradually resume on campus, the...
The Healthcare Worker Exposure Response & Outcomes (HERO) Registry invites US healthcare workers to share clinical and life experiences in order to understand the perspectives and problems faced by those on the COVID-19 pandemic front lines. The registry will unite America’s healthcare workers...
The Institute for Clinical and Translational Science is soliciting applications to qualified and promising scientists early in their faculty careers who have obtained K funding (e.g.: K08, K23, K25, K12, VA) from the NIH or other funding agencies in areas that reflect the mission of the ICTS to...
In response to the University's guidance around COVID-19, ICTS BMI Drop-In Hours will be moving to a virtual format starting this week. Our drop-in hours previously took place in MRF and will now be replaced with a video call through Zoom. Monday 1:00 pm-3:00 pm CST Wednesday 1:00 pm-3:00 pm CST...
With the new development of the Coronavirus Pandemic we would like to bring to the research team attention the potential risk that research subjects could be exposed during a research visit to UIHC. As you know, some of our populations are older, with comorbid conditions and immunosuppressed, which...
TriNetX has become an integral tool for conducting clinical research at the University of Iowa. To honor our most frequent users, we have awarded certificates to four individuals with the most queries from each of the three categories of users: faculty, staff, and students. Learn how these users are utilizing TriNetX to make their research more accurate and to accelerate their findings.
This pilot project aims to answer the questions raised by community members and determine the risk factors and effects of e-cigarettes on the youth.
This pilot grant will work is to improve the efficiency and data quality of physical performance outcomes assessment in multi-site clinical trials and clinical care, in individuals with lower limb musculoskeletal injury and disease.